The Upper Airway Microbiota, Environmental Exposures, Inflammation, and Disease

Abstract

Along with playing vital roles in pathogen exclusion and immune system priming, the upper airways (UAs) and their microbiota are essential for myriad physiological functions such as conditioning and transferring inhaled air. Dysbiosis, a microbial imbalance, is linked with various diseases and significantly impedes the quality of one’s life. Daily inhaled exposures and/or underlying conditions contribute to adverse changes to the UA microbiota. Such variations in the microbial community exacerbate UA and pulmonary disorders via modulating inflammatory and immune pathways. Hence, exploring the UA microbiota’s role in maintaining homeostasis is imperative. The microbial composition and subsequent relationship with airborne exposures, inflammation, and disease are crucial for strategizing innovating UA diagnostics and therapeutics. The development of a healthy UA microbiota early in life contributes to normal respiratory development and function in the succeeding years. Although different UA cavities present a unique microbial profile, geriatrics have similar microbes across their UAs. This lost community segregation may contribute to inflammation and disease, as it stimulates disadvantageous microbial–microbial and microbial–host interactions. Varying inflammatory profiles are associated with specific microbial compositions, while the same is true for many disease conditions and environmental exposures. A shift in the microbial composition is also detected upon the administration of numerous therapeutics, highlighting other beneficial and adverse side effects. This review examines the role of the UA microbiota in achieving homeostasis, and the impact on the UAs of environmental airborne pollutants, inflammation, and disease.

Assessment of the nasal microbiota in dogs with fungal rhinitis before and after cure and in dogs with chronic idiopathic rhinitis.

“…With advances in culture-independent technologies, the role of the upper respiratory tract microbiota in health and disease has become an intense area of research in human medicine [1][2][3][4][5][6][7] and to a much lesser extend in canine medicine 5,8−12 .…”

Editorial: Evolution of Animal Microbial Communities in Response to Environmental Stress

“…Varying inflammatory profiles are associated with specific microbial compositions, while the same is true for many disease conditions and environmental exposures. A shift in the microbial composition is also detected upon the administration of numerous therapeutics, highlighting other beneficial and adverse side effects (Elgamal et al, 2021 ).…”

The Interaction among Microbiota, Epigenetic Regulation, and Air Pollutants in Disease Prevention

“…Environmental exposure, particularly in early life, can result in the development of dysbiosis and consequent diseases [12]. Chemicals, including xenoestrogens, pesticides, and heavy metals, as well as tobacco smoking, alcohol consumption, and medical drug abuse, are major factors that unfavorably influence prenatal development and increase the susceptibility of offspring to later disease development [13].…”